The Importance of HbA1c Control in Patients with Subclinical Hypothyroidism - Zdravlje, medicina, lijecenje, zdravstveni portal

The Importance of HbA1c Control in Patients with Subclinical Hypothyroidism

The Importance of HbA1c Control in Patients with Subclinical Hypothyroidism
Amela Beciragic, Edina Bilic-Komarica
Mat Soc Med. 2012; 24(4): 212-219

View PDF Fulltext

Abstract

Goal: To investigate the correlation between TSH and HbA1c in the treatment of L-thyroxine in the process of glycemic control in patients with subclinical hypothyroidism. Patients and methods: The sample consisted of 100 patients, mean age 51.75±3.23 years, BMI=27.97±4.52 kg/m2, with SH (TSH>4.2 mU/L and normal serum T3 and T4). Laboratory diagnosis included the determination of free T3, free T4, thyroid antibodies, Tg, insulin, C-peptide and glucose during the OGTT, HbA1c, CRP and lipid levels. 20 patients with SH had prediabetes and 38 patients had DM. All patients were treated with low doses of L-thyroxine (25-50ug) and all were physically active. Results: After 6 months of treatment with L-thyroxine, the patients had normal or decreased TSH (5.85±0.92 vs. 3.54±0.55 mU/L), insulin levels (114.64±24.11 vs. 96.44±17.26 pmol/L) significantly reduced HbA1c (6.74±1.01 vs. 6.26±1.12) is reduced. Conclusion: The correlation between TSH and HbA1c was positive and significant (r=0.46). This indicates a significant effect of treatment with L-thyroxine on glycemic control in patients with subclinical hypothyroidism.

REFERENCES

1. Trbojević B. Tiroidna žlezda: Patofiziološke osnove i klinički pristup, Beograd, 1998; 305-310.

2. Manojlović D, Bogić M, Bošković D, Bulajić M, Čolović M, Đorđević P. i ost. Bolesti žlezda sa unutrašnjim lučenjem. U: Interna medicina. Bjeletić D. Ed. Zavod za udžbenike i nastavna sredstva Beograd, Beograd, 1998: 1140-1158.

3. Diez JJ, Iglesias P, Burman KD, Spontaneous normalization of thyrotropin concentations in patients with subclinical hypothyreoidism. J Clin Endocrinol Metab. 2005, 90: 4124-4127.

4. Milošević DP, Đurica S, Davidović M, Stević R, Rajić M, Marković N. Subclinical and manifested hypothyroidism as a consequence of thyroid autoimmune disease. Serbian archives of medicine, Journal of the Serbian medical society. 2005; Suppl 1: 34-39.

5. Bakker SJL, Ter Matten JC, Popp-Snijders C, Slaets JPJ, Heine RJ, Gans ROB. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J Clin Endocrinol Metab. 2001; 86: 1206–1211.

6. Komarica-Bilic E, Beciragic A. Effects of Treatment with L-thyroxin on Glucose Regulation in Patients with Subclinical Hypothyroidism. Med Arh. 2012 Dec; 66(6): 240-242.

7. Fazio S, Palmieri EA, Lombardi G, Biondi B.Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm. 2004; 59: 31-50.

8. Surks MI, OrtizE, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004; 291(2): 228-238.

9. Radaideh A, El-Khateeb M, Batieha AM, Nasser AS, Ajlouni KM. Thyroid function and thyroid autoimmunityin patients with type 1 diabetes mellitus.Saudi Med J. 2003; 24(4): 352-355.

10. Schroner Z, Lazurova I. Diabetes mellitus and subclinical thyroid dysfunctions. Diabetologie Metabolismus Endokrinologie Vyziva. 2006; 9:1: 1-12.

11. Amino N, Tachi J. Hypothyroidism: Etiology and menagment. In: Wheeler MH, Lazarus JH: Diseases of the thyroid, Chapman & Hall, 1994.

12. Phelix P. Baxter J. Frohman LA. The thyroid. In Endocrinology and Metabolism. Graw M.C. Ed. 1995: 435-553.

13. Kovačević T, Lepšanović L.: Endokrinologija. Medicinska knjiga Beograd-Zagreb, 1988.

14. Heljić B. Diabetes mellitus. U: Heljić B, Dilić M, Čengić M, Čengić F, Lončarević N. Diabetes mellitus-klinički aspekti.Sarajevo, Jež, 2002; 16-26.

15. IDF Diabetes Atlas, 2009.

16. Müller MJ, Mitchinson PE, Paschen U, Seitz HJ. Glucoregulatory function of glucagon in hypo-, eu- and hyperthyroid miniature pigs. Diabetologia. 1998; 31: 368-374.

17. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Arch Intern Med. 2000; 160: 526-534.

18. Fatourechi V. Subclinical Hypothyroidism: An Update for Primary Care Physicians. Mayo Clin Proc. 2009; 84(l): 65-71.

19. Glonti S, Jasshi L.Prevalence of subclinical hypothyreosis and subclinical Thyreotoxicosis among females of average and elderlyages who hadntbeen examined before. Georgian Medical News. 2005; 118: 32-35.

20. De Groot LJ, Hoye K, Refetoff S. Serum antigenes and antybodies in the diagnosis of thyroid cancer. J Clin Endocrin Metab. 1980; 45: 1220.

21. Poppe K. et al. Thyroid disease and female reproduction. Clin Endocrinol. 2007; 66: 309–321.

22. Flynn SD, Hishiyama RH, Bigos ST. Autoimmune thyroid disease: immunological, pathological an clinical aspects. Crit Rev Clin Lab Sci. 1988; 26: 43.

23. Hamburger JI. The various presentations of thyroiditis: Diagnostic considerations. Ann Intern Med. 1986; 104: 219.

24. De Groot LJ, Quintans J. The causes of autoimune thyroid disease. Endocrin Rev. 1989; 10: 537.

25. Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R, Muller B. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: A double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab. 2001; 86(10): 4860.

26. Jameson JL, Weetman PA. Disorders of the thyroid gland. In: Kasper LD, Braunwald E, Fauci SA, Hauser LS, Longo LD, Jameson Lj. Harrison s principles of internal medicine, McGraw-Hill: Medical Publishing Division, 16th ed., p. 2104-2027.

27. Arinc H, Gunduz H, Tamer A, Seyfeli E, Kanat M, Ozhan H, Akdemir R, Celebi H, Uyan C. Evaluation of right ventricular function in patients with thyroid dysfunction. Cardiology. 2006: 105(2): 89-94.

28. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004; 291(2): 228-238.

29. Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidismis associated with alow-grade inflammation, increased triglyceride elevel sand predicts cardiovascular disease inmales below 50 years Clin Endocrinol. 2004; 61: 232-238.

30. ImaizumiM, AkahoshiM, IchimaruS, etal.Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab. 2004; 89: 3365-3370.

31. Tuzcua, BahceciM, GokalpD, TuzunY, GunesK. Subclinical hypothyroidism may beassociated with elevated high-sensitive c-reactive protein (lowgradeinflammation) and fasting hyperinsulinemia. EndocrJ. 2005; 52:89-94.Radaideh A, El-Khateeb M, Batieha AM, Nasser AS, Ajlouni KM. Thyroid function and thyroid autoimmunityin patients with type 1 diabetes mellitus. Saudi Med J. 2003; 24(4): 352-355.

32. Heljić B. Diabetes mellitus.U: Heljić B, Dilić M, Čengić M, Čengić F, Lončarević N. Diabetes mellitus-klinički aspekti.Sarajevo : Jež, 2002;16-26. IDF Diabetes Atlas, 2009.

33. Müller MJ, Mitchinson PE, Paschen U, Seitz HJ.Glucoregulatory function of glucagon in hypo-, eu- and hyperthyroid miniature pigs. Diabetologia. 1998; 31: 368–374.

34. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Arch Intern Med. 2000; 160: 526 – 534.

35. Schroner Z, Lazurova I. Diabetes mellitus and subclinical thyroid dysfunctions. Diabetologie Metabolismus Endokrinologie Vyziva. 2006; 9(1): 1-12

Leave a reply

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>